Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2025)

Tango Therapeutics (TNGX) has 6 years of Other Working Capital Changes data on record, last reported at -$1.2 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 105.03% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$3.0 million, down 41.68%, while the annual FY2025 figure was -$3.0 million, 41.68% down from the prior year.
  • Other Working Capital Changes reached -$1.2 million in Q4 2025 per TNGX's latest filing, down from $6.7 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $23.7 million in Q4 2024 and bottomed at -$29.7 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$1.8 million, with a median of -$400500.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: soared 3960.67% in 2021, then plummeted 4225.86% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$4.3 million in 2021, then soared by 438.27% to $14.5 million in 2022, then crashed by 304.58% to -$29.7 million in 2023, then skyrocketed by 179.91% to $23.7 million in 2024, then plummeted by 105.03% to -$1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$1.2 million in Q4 2025, $6.7 million in Q3 2025, and -$7.9 million in Q2 2025.